Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $413611.0.

  • Cryo Cell International's Asset Writedowns and Impairment rose 1544.09% to $413611.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $780197.0, marking a year-over-year decrease of 8324.18%. This contributed to the annual value of $1.3 million for FY2024, which is 6609.95% down from last year.
  • Cryo Cell International's Asset Writedowns and Impairment amounted to $413611.0 in Q3 2025, which was up 1544.09% from $95379.0 recorded in Q2 2025.
  • Cryo Cell International's 5-year Asset Writedowns and Impairment high stood at $3.7 million for Q4 2023, and its period low was $14425.0 during Q2 2021.
  • Over the past 5 years, Cryo Cell International's median Asset Writedowns and Impairment value was $235565.0 (recorded in 2022), while the average stood at $483719.6.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first crashed by 9938.16% in 2021, then soared by 153303.29% in 2022.
  • Cryo Cell International's Asset Writedowns and Impairment (Quarter) stood at $1.2 million in 2021, then crashed by 79.87% to $234452.0 in 2022, then skyrocketed by 1493.99% to $3.7 million in 2023, then tumbled by 90.41% to $358288.0 in 2024, then increased by 15.44% to $413611.0 in 2025.
  • Its Asset Writedowns and Impairment was $413611.0 in Q3 2025, compared to $95379.0 in Q2 2025 and $271207.0 in Q1 2025.